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Abstract
Background: Intra-cardiac thrombus (ICT) and spontaneous echo contrast (SEC) are conside-
red hypercoagulable and inflammatory conditions. We aimed to determine if high sensitivity
C-reactive protein (CRP) and D-dimer (DD), in combination with variables of lower throm-
botic risk (normal ejection fraction [NEF], sinus rhythm [NSR]), may predict the absence of
ICT/SEC.
Methods and Results: Consecutive patients referred for transesophageal echocardiogram
(TEE) for evaluation of cardioembolic source were prospectively enrolled. CRP and DD levels
were determined at the time of TEE. 124 patients were enrolled, of whom 21 had ICT/SEC.
The combination of NSR/NEF had a negative predictive value (NPV) of 98.6% for absence of
ICT/SEC. The NPVs of CRP and DD were 93.6% and 85%, respectively. Adding either CRP or
DD to NSR/NEF combination increased the NPV to 100%. Log CRP was significantly associa-
ted with ICT/SEC.
Conclusions: The presence of NSR and NEF may defer the need for TEE for ICT/SEC
evaluation. CRP association with ICT/SEC suggests that inflammation plays a role in ICT/
/SEC formation. Whether CRP and DD should become routine in the triage process of TEE for
ICT/SEC evaluation requires further large scale prospective studies. (Cardiol J 2012; 19, 3:
267–273)
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Introduction
Transesophageal echocardiography (TEE) is
the most widely used test to evaluate most cardiac
sources of thromboembolism, and is considered the
gold standard to exclude left atrial (LA) thrombi [1].
Cardiogenic source of embolism is an important
contributor to stroke, accounting for approximate-
ly 20% of strokes [2]. TEE is semi-invasive, ope-
rator-dependent, and requires light sedation with
a small but real risk of complications. It would be
desirable to identify patients who could be prospec-
tively triaged to distinguish those who would be-
nefit from TEE to detect intracardiac thrombus
(ICT) and spontaneous echo contrast (SEC) from
those in whom the likelihood of ICT/SEC is very
low and who would be just as well served by a tran-
sthoracic echocardiogram (TTE).
D-dimer (DD) is an indirect marker of fibrin
formation and is an established blood test that re-
flects activation of the coagulation system. DD is
well evaluated in patients with deep venous throm-
bosis (DVT) and pulmonary embolism (PE), with
an excellent negative predictive value [3]. Elevat-
ed DD levels have been described in patients with
atrial fibrillation (AF) with LA thrombus and LA
spontaneous contrast [4, 5]. DD has been associat-
ed with the duration of AF [6], as well as left atrial
appendage (LAA) dysfunction [7].
High sensitivity C-reactive protein (CRP) is
a marker of inflammation and has been shown to
increase the risk of stroke [8]. Elevated CRP leve-
ls are also seen in patients with AF who have
echocardiographic risk factors for thromboembo-
lism [9]. Recently, there has been increasing inter-
est in the inflammatory mechanism of thromboem-
bolism, focusing on the prothrombotic potency of
circulating biomarkers.
We sought to determine the value of DD and
CRP in evaluating ICT and SEC, and to determine
if these markers, when combined with clinical and
echocardiographic variables, could help identify
patients with low suspicion for intracardiac throm-
boembolic source in which TEE can be deferred.
Methods
Consecutive patients referred for TEE for evalu-
ation of a cardiac source of thromboembolism at
Henry Ford Hospital were evaluated prospective-
ly. Exclusion criteria were: acute coronary syn-
drome within the previous three months, chronic
infection, active bleeding, blood transfusion within
the previous month, surgery within the previous
three months, DVT or PE within the previous three
months, thrombolytic therapy in stroke patients, an-
ticoagulant therapy for more than seven days (since
coumadin therapy decreases DD level [10]), mali-
gnancy, and autoimmune diseases. The project was
approved by the institutional review board. Informed
consent was obtained from all enrolled patients.
All TEEs were done after signed patient con-
sent using a combination of midazolam and demerol
for sedation. A Philips 5500 (Philips, Andover,  MA,
USA) Sonos ultrasound machine with an equipped
multiplane TEE probe was used for all TEEs. CRP
and DD levels were measured at the time of the
TEE. All TEEs were performed and interpreted by
experienced American Society of Echocardiography
Level 2 or 3 equivalent echocardiographers. TEEs
were then interpreted for the purpose of this study
by an experienced level 3 echocardiographer (KA)
who was blinded to the patients’ conditions and labo-
ratory results. TEE was considered the gold stan-
dard for determining ICT/SEC.
Global left ventricular function was described
as normal when estimated ejection fraction (EF)
was ≥ 50%, and described as reduced when EF
< 50%. Mitral regurgitation (MR) was assessed by
visual estimation as the percentage of MR jet area
to LA area based on American Society of Echocar-
diography guidelines for quantification for native
valve regurgitation [11]. Patients with moderate to
severe MR were grouped together as having sig-
nificant MR, while those with no, trivial or mild MR
were labeled as having no significant MR. SEC was
defined as a finely reticular pattern of dynamic,
swirling intracavitary echoes imaged with gain set-
tings adjusted to distinguish background ‘white’
noise [12]. SEC was classified as mild when loca-
lized to LA or LAA, moderate when seen intermit-
tently with adjustment of gain settings, and severe
when present continuously at normal gain settings.
ICT was defined as an echodense mass adjacent to
the endocardial surface clearly differentiated from
such normal structures as pectinate muscles. If
thrombus and contrast were seen at the same time,
the patient was labeled as having a thrombus only.
LAA velocities were measured at end-diastole and
averaged over 3–6 cardiac cycles.
CRP assay was manufactured by Behring (part
of Siemens Diagnostics). It had a low limit of sensi-
tivity of 0.0176 mg/dL. Intra-assay coefficient of
variation was < 0.7%. Inter-assay coefficients of
variation were 8% at 0.15 mg/dL and 6% at 0.45 mg/
/dL. DD assay was manufactured by Stago. DD had
a low limit of sensitivity of 0.22 mg/mL (FEU). In-
tra-assay coefficients of variation were 0.04 SD at
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0.29 mg/mL, and 0.06 SD at 2.71 mg/mL. Inter-
-assay coefficients of variation were 0.05 SD at
0.32 mg/mL, and 0.14 SD at 2.76 mg/mL.
Statistical analysis
SAS version 9.3 software was used for statis-
tical analysis. Categorical data was reported as pro-
portions and continuous data as mean values with
standard deviations. Sensitivity, specificity, positive
predictive value (PPV) and negative predictive val-
ue (NPV) of CRP and DD for ICT/SEC were calcu-
lated using standard formulas. The median of CRP
and DD was used for these calculations since their
values were skewed. Sensitivity and specificity of
CRP and DD were compared using the receiver
operating characteristics (ROC) curve procedure.
Spearman’s correlation coefficient (r) was calculat-
ed to determine the relationship between CRP, DD,
and ICT/SEC. Logarithmic transformation was used
for CRP and DD to determine their association with
ICT/SEC. Stepwise logistic regression analysis
using a backward selection process was used to
identify independent predictors of ICT/SEC. For all
statistical analysis, a p value of less than 0.05 was
considered statistically significant.
Results
We prospectively screened 168 consecutive
patients referred for TEE for evaluation of a cardi-
ac source of thromboembolism between April 2005
and July 2006. Figure 1 shows the flow-chart dia-
gram of the patients screened and further enrolled.
Twenty five patients were excluded as per the ex-
clusion criteria described. In addition, ten patients
refused to participate, eight patients were not com-
petent to sign a consent form (Michigan state law
does not allow a guardian to sign a consent form for
enrolment in a study), and one patient was exclud-
ed because of a technically difficult TEE.
Of the patients with ICT/SEC (n = 21), the
majority (17 patients) had LA SEC and four had LA/
/LAA thrombus. One LA thrombus was in the LA,
and three were in the LAA. SEC was mild in seven
patients, moderate in eight patients, and severe in
two patients. ICT/SEC was exclusively seen in the
LA/LAA. Furthermore, one patient from the stroke/
/transient ischemic attack (TIA) group had ICT and
four had SEC. Two patients from the AF group had
ICT and 11 had SEC; whereas in the group with both
stroke/TIA and AF, one patient had ICT and two
had SEC (Fig. 1). Figure 2 is a representative ex-
ample of a study patient with SEC, and Figure 3 of
a study patient with a large ICT in the LA.
Mean CRP level was 1.18 ± 2.1 mg/L while
mean DD level was 993 ± 2,057 µg/L. Median va-
lue for CRP was 0.713 (lower quartile 0.187, upper
quartile 1.13) mg/L and for DD 421 (lower quartile
264, upper quartile 866) µg/L. Area under the curve
for CRP and DD were 0.77 and 0.69, respectively.
Intraobserver (KA) correlation coefficient for both
SEC and ICT was 0.98.
Table 1 shows baseline characteristics for in-
cluded patients according to the presence or ab-
sence of ICT/SEC. Patients with ICT/SEC were
predominantly male (90% vs 58%, p = 0.005) and
Figure 1. Flow-chart diagram of the patients screened
and enroled in the study; AF — atrial fibrillation; ICT —
intracardiac thrombus; SEC — spontaneous echo con-
trast; TIA — transient ischemic attack.
Figure 2. Transesophageal echocardiogram short axis
aortic valve level of a study patient showing left atrial
appendage on the right side of screen with spontane-
ous echo contrast.
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< 0.0001), lower LAA velocity (41.3 ± 23.8 cm/s
vs 70.0 ± 26.3 cm/s, p < 0.001) and increased dias-
tolic LAA area (5.2 ± 2.2 cm2 vs 3.9 ± 1.5 cm2, p =
= 0.017). There was a trend that higher hemoglobin
was associated with ICT/SEC (p = 0.055). Patients
with ICT/SEC had higher log CRP (p = 0.009),
whereas DD level or log DD were not statistically
different between the two groups.
Table 2 shows the sensitivity, specificity, PPV
and NPV of AF, low EF, CRP, DD, and their combi-
nation. As mentioned above, median values of CRP
and DD were used for these calculations. A cut-off
of 500 µg/L for DD, which is the standard cut-off
used in DVT and PE evaluation [13], provided the
same results as the median value (420 µg/L) and
was used for the analysis. The NPV of AF or low
EF was 93–94%. The combination of AF and low
EF provided a NPV of 98.6% (71 out of 72 patients).
The NPVs of elevated CRP and DD were 93.6% and
85%, respectively. Combining DD and CRP did not
enhance NPV (93%). On the other hand, adding
either CRP or DD to the combination of AF and low
EF increased NPV to 100%.
Figure 3. Transesophageal echocardiogram short axis
aortic valve level of a study patient showing left atrial
appendage (LAA) on the right side of screen with LAA
thrombus from a study patient.
Table 1. Baseline characteristics.
Clinical, laboratory and echocardiographic No ICT/SEC ICT/SEC P
variables  (n = 103) (n = 21)
Age [years] 55.8 ± 12.7 53.5 ± 14.9 0.48
Male gender 60 (58%) 19 (90%) 0.005
African-American origin 61 (59%) 13 (62%) 0.82
Atrial fibrillation/flutter 21 (20%) 16 (76%) < 0.001
Previous stroke 18 (18%) 1 (5%) 0.12
Coronary artery disease 16 (16%) 4 (19%) 0.69
Congestive heart failure 14 (14%) 8 (38%) 0.007
Obesity (BMI > 30 kg/m2) 47 (46%) 8 (38%) 0.53
Hypertension 71 (69%) 16 (76%) 0.51
Diabetes mellitus 38 (37%) 5 (24%) 0.25
Hyperlipidemia 53 (51%) 8 (38%) 0.26
Smoking 33 (32%) 4 (19%) 0.24
Mean D-dimer [µg/L] 1045 ± 2228 734.8 ± 602 0.23
Log D-dimer [µg/L] 6.3 ± 1.0 6.3 ± 0.7 0.82
Mean CRP [mg/L] 1.1 ± 2.3 1.8 ± 2.2 0.2
Log CRP [mg/L] –0.8 ± 1.3 0.1 ± 1.1 0.009
Hemoglobin [g/dL] 13.1 ± 1.8 13.9 ± 1.9 0.055
Ejection fraction < 50% 23 (22.3%) 15 (71.4%) < 0.0001
Mean ejection fraction [%] 52 ± 16 36 ± 15 < 0.0001
Left atrial appendage velocity [cm/s] 70.0 ± 26.3 41.3 ± 23.8 < 0.001
Diastolic left atrial appendage area [cm2] 3.9 ± 1.5 5.2 ± 2.2 0.017
Left atrial diameter [cm] 4.9 ± 4.8 5.4 ± 0.8 0.36
Aortic valve sclerosis 33 (34%) 6 (30%) 0.71
Significant mitral regurgitation 14 (14%) 5 (24%) 0.24
Continuous variables are expressed as mean ± standard deviation; ICT — intracardiac thrombus; SEC — spontaneous echo contrast;
BMI — body mass index; CRP — C-reactive protein.
with AF (76% vs 20%, p < 0.001). Regarding
echocardiographic variables, ICT/SEC was associ-
ated with lower EF (36 ± 15% vs 52 ± 16%, p <
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Log CRP was associated with ICT/SEC (0.1 ±
± 1.1 mg/L vs –0.8 ± 1.3 mg/L, p = 0.009), while
log DD did not have a significant association. Us-
ing stepwise logistic regression with backward se-
lection (Table 3), EF (p = 0.0063 for a change of
1%), AF (p < 0.001), and log CRP (p = 0.023 for
a change of 0.1 mg/L), were associated with ICT/
/SEC. Significant MR was associated with a reduced
risk for ICT/SEC (p = 0.046). Multiple regression
analysis was also performed by including variables
with p < 0.25 in univariate analysis in addition to
log DD since it is a variable of interest. In this mo-
del, only log CRP (p = 0.01 for 0.1 mg/L change) was
associated with ICT/SEC, while significant MR was
associated with a reduced risk for it (p = 0.025). In
addition, log CRP showed a significant correlation
with log DD (r = 0.44, p < 0.0001) and with ICT/
/SEC (r = 0.24, p = 0.0063).
Discussion
In this prospective study, we evaluated the role
of CRP and DD along with TEE to predict ICT/SEC.
We found that the combination of normal sinus
rhythm (NSR) and normal EF (NEF) identified
a group of patients who were unlikely to have ICT/
/SEC (NPV = 98.6%) and for whom TEE could be
deferred. The one patient with ICT/SEC in our
study who had NEF and NSR had severe left ven-
tricular hypertrophy and was found to have mild
SEC. CRP and DD levels were elevated in that pa-
tient. Thus, adding either marker to NSR and NEF
increased NPV to 100%.
CRP was significantly associated with ICT/SEC
and elevated CRP had better NPV than DD. To the
best of our knowledge, this is the first study to have
found an association between CRP and ICT/SEC in
multivariate analysis. Inflammation may influence
the prothrombotic state by the production of tissue
factors from monocytes, increased platelet activa-
tion, and by endothelial damage [14]. A strong as-
sociation between increased hematocrit and SEC in
patients with AF was demonstrated, and although
CRP and interleukin-6 were also univariate predic-
tors, they did not predict SEC.
This and other studies have demonstrated that,
at least in AF, a close association exists between
a prothrombotic milieu and inflammatory markers
such as CRP [15–17]. Our study thus extends the
findings of an inflammatory marker such as CRP
potentially being of value in predicting the presence
of ICT/SEC, in addition to simple variables deter-
mined by electrocardiogram and TTE as discussed
Table 2. Sensitivity, specificity, PPV and NPV for intracardiac thrombus or contrast.
Number with ICT and SEC/total number (%)
Sensitivity Specificity PPV NPV
AF 16/21 (76%) 82/103 (80%) 16/37 (43%) 82/87 (94.3%)
EF < 50% 15/21 (71%) 80/103 (78%) 15/38 (40%) 80/86 (93%)
CRP > 0.713 mg/L 17/21 (81%) 58/103 (56%) 17/62 (27%) 58/62 (93.6%)
DD > 500 µg/L 11/21 (52%) 57/103 (55%) 11/57 (19%) 57/67 (85%)
AF and EF < 50% 20/21 (95%) 71/103 (69%) 20/52 (39%) 71/72 (98.6%)
AF and EF < 50% 21/21 (100%) 45/103 (44%) 21/79 (27%) 45/45 (100%)
and DD > 500 µg/L
AF and EF < 50% 21/21 (100%) 44/103 (43%) 21/80 (26%) 44/44 (100%)
and CRP > 0.713 mg/L
CRP > 0.713 mg/L 18/21 (86%) 40/103 (39%) 18/81 (22%) 40/43 (93%)
and DD > 500 µg/L
PPV — positive predictive value; NPV — negative predictive value; ICT — intracardiac thrombus; SEC — spontaneous echo contrast; AF — atrial
fibrillation; EF — ejection fraction; CRP — C-reactive protein; DD — D-dimer
Table 3. Significant variables with an association
with ICT/SEC using stepwise logistic regression
analysis with backward selection.
Variable Odds ratio 95% CI P
Sinus rhythm 0.04 0.01–0.20 < 0.001
Ejection fraction 0.75 0.61–0.92 0.0063
(change of 1%)
Log CRP (change 1.08 1.01–1.15 0.023
of 0.1 mg/L)
Significant mitral 0.18 0.04–0.97 0.046
regurgitation
ICT — intracardiac thrombus; SEC — spontaneous echo contrast;
CI — confidence interval; CRP — C-reactive protein
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above. Previous studies have revealed an associa-
tion between graded levels of SEC and increased
DD levels in patients with nonvalvular AF [5]. How-
ever, our study is different in that a different DD
assay was used (ELISA), the exclusion criteria were
more stringent, and patients with conditions other
than AF were also enroled. These could potential-
ly explain the lack of association between DD and
ICT/SEC in our study.
Significant MR was found to be protective
against ICT/SEC in our study. This association has
been described before [18] and could be explained
by the washout effect of regurgitant MR jet prevent-
ing ICT formation on the atrial surface and in LAA.
Our study also demonstrated a trend for an asso-
ciation between ICT/SEC and hemoglobin
(p = 0.055). This may be explained by increased
concentration of erythrocytes or indirectly by pro-
moting stasis due to altered rheology. SEC may
represent interaction between erythrocytes and
macromolecules during conditions of blood-pool
stasis with a higher hematocrit being associated
with SEC [14]. However, in the same context, it is
interesting to note that low hemoglobin does not
necessarily protect against SEC as previously
shown by our group [19].
Previous studies have also shown that TEE is
a more accurate technique for the evaluation of ICT
than TTE [1]. The sensitivity of TTE has been
plagued by a lack of adequate visualization of the
LAA which harbors over 90% of ICT, particularly
in patients with AF. However, predicting the like-
lihood of thrombus based on the presence or ab-
sence of structural heart disease by TTE has been
evaluated by other earlier investigations. Ellis et al.
[18] described how a structurally normal heart, as
determined by TTE, provides 100% NPV for ICT.
A large echocardiographic database study of 20,643
TEE examinations in patients with NSR demon-
strated only 20 cases of LA thrombi. Twelve out of
these 20 patients had underlying mitral or aortic
disease or valvular prosthesis [20]. Omran et al. [21]
studied 869 patients in two groups: those with AF
as the control group (n = 286) and those with NSR
as the study group (n = 583) who were referred for
a TEE for evaluation of ICT. All the six (1%) pa-
tients with NSR who had ICT had underlying struc-
tural heart disease. They concluded that in patients
with NSR and no structural heart disease as as-
sessed by TTE, routine TEE was not indicated for
the evaluation of ICT.
Several clinical and echocardiographic varia-
bles have been proposed as predictors of LAA
thrombi by TEE,  such as large stroke, history of
coronary artery disease, evidence of electrocardio-
graphic ischemia [22], as well as mitral stenosis, AF,
tricuspid regurgitation, valvular prosthesis, left
ventricular dysfunction, and right ventricular dys-
function [18]. However, our study suggests that two
simple parameters, namely NSR and normal LV
function, in combination, have a very high NPV
(98.6%) which when combined with hematologic
markers such as CRP or DD raises the NPV to 100%.
Although our study focused on consecutive pa-
tients referred for TEE assessment of ICT/SEC, it
raises important questions as to whether routine TEE
would be warranted in some patients with NSR and
NEF on TTE. This is a particularly hotly debated is-
sue in patients presenting to the echo lab for workup
of ischemic stroke, because the role of TEE remains
ill-defined [23, 24]. Although previous studies have
suggested that TEE is not warranted in all ischemic
stroke patients if they are in NSR and have normal
TTE [20, 25], others have suggested that TEE adds
incremental value for decision making for anticoagu-
lation, and should be part of the routine work-up in
patients with ischemic stroke [26, 27].
If the results of our study could be prospective-
ly confirmed in a large series of ischemic stroke
patients, more effective use of TEE in selected
patients who are candidates for anticoagulation with
a high suspicion for atheromatous disease of the
aortic arch could be pursued. Lower risk patients
can be treated with a diagnostic strategy starting
with TTE with harmonic imaging and saline con-
trast study, along with use of CRP and DD.
Limitations of the study
Conclusions should only be applied to the assay
for CRP and DD used in this study. Since two groups
(AF and stroke/TIA) were evaluated and ICT/SEC
was noticed more in the AF group, it is possible that
the association of CRP with ICT/SEC may be second-
ary to its association with AF. To evaluate this possi-
bility, we compared log CRP between the two groups
in patients without ICT/SEC; the difference was not
significant (p = 0.09). We were unable to evaluate each
group separately because of the limited sample size.
There was no control population in the study.
Conclusions
The presence of NSR and NEF in patients re-
ferred for TEE has a very high negative predictive
value for ICT/SEC. This, in combination with sim-
ple biomarkers such as CRP or DD, may be helpful
in triaging which patients need further semi-inva-
sive tests such as TEE. Thus, further studies ran-
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domizing patients to using this strategy of initial
TTE, rhythm and inflammatory marker assessment
vs routine TEE may be helpful in determining
the implications of our findings towards selective
triage of patients to TEE.
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